Oral treatment of scabies with ivermectin, which is not yet registered
for this indication, appears to be an effective, inexpensive treatmen
t with negligible side effects. We present the current clinical experi
ence in the treatment of scabies with ivermectin as well as the availa
ble pharmacological data. For endemic scabies or unreliable or immun-c
ompromised patients, ivermectin offers an effective systemic treatment
of scabies.